Atjaunināt sīkdatņu piekrišanu

E-grāmata: Novel Molecular Oncotargets and Nano-Oncotherapeutics

  • Formāts: 779 pages
  • Izdošanas datums: 15-Jun-2023
  • Izdevniecība: Cambridge Scholars Publishing
  • ISBN-13: 9781527507142
Citas grāmatas par šo tēmu:
  • Formāts - PDF+DRM
  • Cena: 162,79 €*
  • * ši ir gala cena, t.i., netiek piemērotas nekādas papildus atlaides
  • Ielikt grozā
  • Pievienot vēlmju sarakstam
  • Šī e-grāmata paredzēta tikai personīgai lietošanai. E-grāmatas nav iespējams atgriezt un nauda par iegādātajām e-grāmatām netiek atmaksāta.
  • Formāts: 779 pages
  • Izdošanas datums: 15-Jun-2023
  • Izdevniecība: Cambridge Scholars Publishing
  • ISBN-13: 9781527507142
Citas grāmatas par šo tēmu:

DRM restrictions

  • Kopēšana (kopēt/ievietot):

    nav atļauts

  • Drukāšana:

    nav atļauts

  • Lietošana:

    Digitālo tiesību pārvaldība (Digital Rights Management (DRM))
    Izdevējs ir piegādājis šo grāmatu šifrētā veidā, kas nozīmē, ka jums ir jāinstalē bezmaksas programmatūra, lai to atbloķētu un lasītu. Lai lasītu šo e-grāmatu, jums ir jāizveido Adobe ID. Vairāk informācijas šeit. E-grāmatu var lasīt un lejupielādēt līdz 6 ierīcēm (vienam lietotājam ar vienu un to pašu Adobe ID).

    Nepieciešamā programmatūra
    Lai lasītu šo e-grāmatu mobilajā ierīcē (tālrunī vai planšetdatorā), jums būs jāinstalē šī bezmaksas lietotne: PocketBook Reader (iOS / Android)

    Lai lejupielādētu un lasītu šo e-grāmatu datorā vai Mac datorā, jums ir nepieciešamid Adobe Digital Editions (šī ir bezmaksas lietotne, kas īpaši izstrādāta e-grāmatām. Tā nav tas pats, kas Adobe Reader, kas, iespējams, jau ir jūsu datorā.)

    Jūs nevarat lasīt šo e-grāmatu, izmantojot Amazon Kindle.

This book describes the latest findings related to tumor molecular microenvironment and its involvement in cancer progression. It includes authoritative articles on recent progress in the field based on the current results of apoptosis, autophagy, and tumor signaling highlight new cancer targets for therapeutic manipulation as a strategy of cancer control. It explores the advancements of molecular mechanisms in oncology to identify new therapeutic, prognostic, and diagnostic targets in the molecular events of neoplasia. Recent data on nanoformulations in the book for the therapeutic management of various types of cancer indicate a revolutionary change in cancer therapy in the near future. The primary audience of this book is students and faculties from academic institutions, the researchers, scientists, clinicians, and scientists belong to the research and development wing in industries, as the book provides the latest data and findings in the described areas as a valuable source of incredible information in the field in an organized manner.
Biswajit Mukherjee, Ph.D., W.B.C.S., F.I.C., F.I.C.S., is Professor and former Head of the Department of Pharmaceutical Technology, Jadavpur University, Kolkata, and a former faculty member of the University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh. He was a DAAD (German Academic Exchange Services) Fellow and Guest Scientist, German Cancer Research Center (DKFZ), Heidelberg. He has been working on cancer biology and chemoprevention with Antisense Technology, nanomedicine, and targeted drug delivery with Pharmacokinetic and Pharmacodynamic approaches. He is the former Coordinator of QIP (Quality Improvement Program, All India Council of Technical Education, Govt. of India) Nodal Cell (Pharmacy). He is also the Coordinator of the Center for Advanced Research in Pharmaceutical Sciences, Jadavpur University. He was the recipient of the University Grants Commission (UGC) (Government of India) research award in 2009. He received the prestigious CJ Shioo research award in 2016 from the Association of Pharmaceutical Teachers of India. Recently he authored a book entitled "Pharmacokinetics: Basics to Applications" and edited a book titled "Nanotherapeutics for the Treatment of Hepatocellular Carcinoma."